Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
Annals of Surgical Oncology|October 13, 2018
Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?Matthew C Perez, Daniel E Oliver, Evan S Weitman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanismsKim H T Paraiso, H Eirik Haarberg, Elizabeth Wood, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2019
BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T CellsCigdem Atay, Taekyoung Kwak, Sergio Lavilla-Alonso, et al.Frontiers in Oncology|March 20, 2018
Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic MelanomaJohn E Mullinax, MacLean Hall, Sangeetha Prabhakaran, et al.Cancer|June 4, 2015
Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinomaFranz O Smith, Binglin Yue, Suroosh S Marzban, et al.Annals of Surgical Oncology|August 4, 2018
Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?Matthew C Perez, Felipe R de Pinho, Amanda Holstein, et al.Oncotarget|March 20, 2016
Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activationHyeran Sung, Krishna L Kanchi, Xue Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2025
Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 StudyTheresa Medina, Jason A Chesney, Harriet M Kluger, et al.Molecular Cancer Therapeutics|April 24, 2024
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0Joseph Markowitz, Michael Shamblott, Andrew S Brohl, et al.Oncoimmunology|September 20, 2018
Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancerMichael Poch, MacLean Hall, Autumn Joerger, et al.Pageof 8